PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Molecular Innovation, Feinstein Institute of Bioelectronic Medicine Feinstein Institutes for Medical Research, Northwell Health 350 Community Drive, Manhasset, NY 11030, USA.\', \'Robert S. Boas Center for Genomics & Human Genetics, Feinstein Institute of Molecular Medicine Feinstein Institutes for Medical Research, Northwell Health 350 Community Drive, Manhasset, NY 11030, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4155/fmc-2020-0180
?:doi
?:hasPublicationType
?:journal
  • Future medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 32672061
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.111
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all